Other languages PolyPid Ltd.

Equities

PYPD

IL0011326795

Market Closed - Nasdaq Other stock markets 16:30:00 2024-04-26 EDT			5-day change	1st Jan Change
4.752 ^USD	-1.12%		+8.01%	+25.07%

02-14	Transcript : PolyPid Ltd., Q4 2023 Earnings Call, Feb 14, 2024
02-14	PolyPid Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PolyPid Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-14
PolyPid Ltd. Announces Enrollment of the 100th Patient in the Ongoing Shield II Phase 3 Trial	02-12
PolyPid Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08
Polypid Announces the Addition of Dr. Nurit Tweezer-Zaks to Its Board of Directors	11-07
Polypid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-Plex100 and Plex Technology Platform	23-10-04
Top Premarket Decliners	23-09-27
Top Premarket Decliners	23-09-26
PolyPid Facility for D-PLEX100 Has no Critical Findings From Israeli Health Ministry Audit	23-09-21
PolyPid to Implement 1-for-30 Reverse Stock Split	23-09-20
PolyPid Ltd. Announces Successful Completion of Manufacturing Process Validation for D-PLEX100	23-09-19
PolyPid Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Polypid Ltd. Announces New Publication Highlighting Potent Antibacterial Activity of D-Plex Against Susceptible and Resistant Bacteria for the Prevention of Surgical Site Infections	23-06-29
PolyPid Ltd. Announces Recruitment of First Patient in Revised Shield Ii Phase 3 Trial Evaluating D-Plex100 for Prevention of Abdominal Colorectal Surgical Site Infections	23-06-22
PolyPid Ltd Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX100 for Prevention of Abdominal Colorectal Surgical Site Infections	23-05-22
PolyPid Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
PolyPid Ltd. Announces Board Changes	23-05-10
PolyPid Ltd. Auditor Raises 'Going Concern' Doubt	23-03-30
PolyPid Launches Proposed Public Ordinary Share Offering; Shares Down in After-Market Hours	23-03-29
PolyPid Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-08
PolyPid Provides Positive Regulatory Update for D-PLEX100 for the Prevention of Surgical Site Infections in Abdominal Colorectal Surgery	23-01-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PolyPid Ltd.

Equities

PYPD

IL0011326795

Other languages

Filters